Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2024 16:10 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a...
July 26, 2024 21:25 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
July 22, 2024 21:55 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Provides Update on Previously Announced Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
July 19, 2024 09:47 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Second Upsizing of Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a...
June 20, 2024 17:34 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting

VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
May 30, 2024 17:52 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...
May 24, 2024 16:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that...
May 23, 2024 07:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement

All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a...
May 08, 2024 08:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new...
April 26, 2024 20:38 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based...